Lululemon Athletica Inc. (LULU) is having itself a morning. The athletic apparel maker's shares rocketed 9% higher in premarket trading, climbing to $203.82, after the company delivered third-quarter results that blew past Wall Street's expectations and raised its outlook for the full year.

The numbers tell the story pretty clearly. Lululemon reported quarterly earnings of $2.59 per share, crushing analyst estimates of $2.27 by a solid 14.15%. Revenue came in at $2.57 billion, topping the Street's $2.48 billion expectation and marking a healthy increase from the $2.4 billion the company posted in the same quarter last year.

Beyond the strong quarterly performance, Lululemon also announced a CEO succession plan and authorized an expansion of its share buyback program, giving investors additional reasons to feel optimistic about the company's direction.

But Lululemon wasn't the only name making moves before the opening bell. Here's a look at the other stocks experiencing significant premarket action.

The Winners

cbdMD, Inc. (YCBD) absolutely exploded in premarket trading, jumping 57.6% to $0.9870. The catalyst? The company announced it had successfully regained full compliance with NYSE American listing standards, removing the cloud of potential delisting that had been hanging over the stock.

Paranovus Entertainment Technology Ltd. (PAVS) surged 52.2% to $0.0525 in premarket trading, bouncing back after declining 9% on Thursday.

Neo-Concept International Group Holdings Limited (NCI) climbed 33% to $1.65 in early trading.

Tilray Brands, Inc. (TLRY) rose 26.6% to $10.68 in premarket action following the company's announcement of its Amped Live Resin Liquid Diamond product line, showing that product innovation continues to resonate with investors in the cannabis space.

Quanex Building Products Corporation (NX) gained 22% to $18.38 premarket after delivering fourth-quarter financial results that exceeded analyst expectations.

Akanda Corp. (AKAN) shares jumped 20.5% to $0.9477 in premarket trading. According to an SEC filing submitted on Tuesday, shareholders approved a share consolidation proposal.

Canopy Growth Corporation (CGC) gained 20.3% to $1.36 in premarket trading, joining the broader rally in cannabis names.

Kaival Brands Innovations Group, Inc. (KAVL) gained 8% to $0.2160 in premarket trading after declining 20% on Thursday.

RH (RH) surged 3.1% to $158.00 in premarket trading after the luxury home furnishings retailer posted mixed results for the third quarter following Thursday's closing bell.

The Losers

Applied Therapeutics Inc. (APLT) fell 37.8% to $0.14 in premarket trading after Cycle Pharmaceuticals announced plans to acquire the company. Despite being an acquisition target, the stock's sharp decline suggests investors aren't thrilled with the terms or prospects of the deal.

Clearone Inc. (CLRO) tumbled 14.6% to $5.37 in premarket trading, giving back some of Thursday's 13% gain.

Mawson Infrastructure Group Inc. (MIGI) fell 14.4% to $5.22 in premarket trading after already declining around 9% on Thursday, extending its losing streak.

Black Titan Corp. (BTTC) fell 14.2% to $3.53 in premarket trading, reversing course after surging 24% on Thursday.

Brenmiller Energy Ltd. (BNRG) fell 13.2% to $0.82 in premarket trading after already dipping 16% on Thursday.

Beasley Broadcast Group Inc. (BBGI) declined 12.2% to $7.76 in premarket trading, continuing its slide after dropping 47% on Thursday.

Movano Inc. (MOVE) shares dipped 11.8% to $7.95 in premarket trading after declining 3% on Thursday.

LightPath Technologies Inc. (LPTH) dipped 6.1% to $8.57 in premarket trading after the company announced a proposed public offering of common stock. Dilution fears tend to weigh on shares, and this case was no exception.

Broadcom Inc. (AVGO) dipped 5% to $386.28 in premarket trading, despite reporting better-than-expected results for the fourth quarter and issuing strong first-quarter sales guidance. Sometimes even good news isn't good enough when expectations run sky-high.

Vale SA (VALE) fell 3.6% to $12.81 in premarket trading. The decline is somewhat puzzling given that RBC Capital analyst Marina Calero upgraded Vale from Sector Perform to Outperform on Wednesday and raised the price target from $11 to $14.2.